|
| Home : ViewRay Announces China NMPA Approval of its MRIdian® MRI-Guided Radiation Therapy for Cancer Patients |
|
Sep 07
2022 |
ViewRay Announces China NMPA Approval of its MRIdian® MRI-Guided Radiation Therapy for Cancer Patients |
|
This approval expands MRIdian's global reach and offers cancer patients a new radiation therapy option—MRIdian SMART DENVER, Sept. 7, 2022 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that the company's MRIdian MRI-Guided Radiation Therapy System has received approval from... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/viewray-announces-china-nmpa-approval-of-its-mridian-mri-guided-radiation-therapy-for-cancer-patients-301618507.html |
| |
|
Related News
|
» Saucy Santana and Coi Leray to Perform at The Model Experience New York Fashion Week (NYFW) Event
» Putin, Xi to meet in Uzbekistan next week, official says
|
|
|
